As a top 10 global MNC, how does Lilly’s Indonesian affiliate compare with the group’s global positioning? Lilly Indonesia’s…

Since 1969, Eli Lilly & Company has been investing in Belgium. Can you give our readers a brief overview of the company’s history here and…

You were recently appointed at the head of Eli Lilly South African operations. What is the specific mission you have been given? Eli Lilly South…

You have just arrived as general manager in January 2011. Coming to a new market obviously means a new context, different challenges and so on. Can…

Lilly’s portfolio ranges from products for cardiovascular diseases to neurological conditions. How has your portfolio developed in Chile? What…

An important topic in Brazil is access to drugs. In recent interviews we have spoken about a third of MS patients being treated, or 10% of…

Having been director here in India between 1998-2002, and then again since 2006, you have clearly been in the front seat to observe the evolution of…

You joined Eli Lilly Poland in November 2008 as a Marketing Director and you have been leading the affiliate since January 2010. Moreover you are…

Please can you tell us in your own words how you’ve seen the Mexican pharmaceutical market change over the past five years? Mexico is one of…

You began as managing director of this Dutch affiliate close to one year ago. What was the trajectory that led you to this position and what were your…

You have spent much of your time working in the USA and came to Malaysia in 2008 as Country Manager. What were your expectations of Malaysia before…

Traditionally and historically, Lilly is very strong in the Asian region. The company has placed a great deal of emphasis on the region for many…